ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103 | -1.0% | 34,497 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $104 | -44.7% | 31,179 | -20.1% | 0.00% | -50.0% |
| Q4 2022 | $188 | -100.0% | 39,042 | -50.5% | 0.00% | -66.7% |
| Q3 2022 | $449,000 | -3.2% | 78,839 | +20.7% | 0.01% | +20.0% |
| Q2 2022 | $464,000 | +199.4% | 65,320 | +276.2% | 0.01% | +400.0% |
| Q4 2021 | $155,000 | -88.3% | 17,361 | -53.9% | 0.00% | -83.3% |
| Q3 2021 | $1,321,000 | +908.4% | 37,684 | +1678.4% | 0.01% | +500.0% |
| Q1 2021 | $131,000 | – | 2,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |